FDA OKs Xofluza, First New Flu Antiviral in Nearly 20 Years

Baloxavir marboxil is for the treatment of acute uncomplicated influenza in people age 12 years and older who have been symptomatic for no more than 48 hours.
FDA Approvals …read more